Rinaldi, L.; Nevola, R.; Franci, G.; Perrella, A.; Corvino, G.; Marrone, A.; Berretta, M.; Morone, M.V.; Galdiero, M.; Giordano, M.;
et al. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics. Cancers 2020, 12, 1351.
https://doi.org/10.3390/cancers12061351
AMA Style
Rinaldi L, Nevola R, Franci G, Perrella A, Corvino G, Marrone A, Berretta M, Morone MV, Galdiero M, Giordano M,
et al. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics. Cancers. 2020; 12(6):1351.
https://doi.org/10.3390/cancers12061351
Chicago/Turabian Style
Rinaldi, Luca, Riccardo Nevola, Gianluigi Franci, Alessandro Perrella, Giusy Corvino, Aldo Marrone, Massimiliano Berretta, Maria Vittoria Morone, Marilena Galdiero, Mauro Giordano,
and et al. 2020. "Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics" Cancers 12, no. 6: 1351.
https://doi.org/10.3390/cancers12061351
APA Style
Rinaldi, L., Nevola, R., Franci, G., Perrella, A., Corvino, G., Marrone, A., Berretta, M., Morone, M. V., Galdiero, M., Giordano, M., Adinolfi, L. E., & Sasso, F. C.
(2020). Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics. Cancers, 12(6), 1351.
https://doi.org/10.3390/cancers12061351